Stay updated on Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.

Latest updates to the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a minor revision update: Revision: v3.3.2 replacing v3.3.1; there is no visible change to core study content, eligibility criteria, or study outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedPublications section now states that items are automatically filled from PubMed. The revision history has been updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check26 days agoChange DetectedAdded a 'Results Submitted' status and updated two Taiwan locations from 'Tainan City, Taiwan, 704' and 'Tainan City, Taiwan, 736' to 'Tainan, Taiwan, 704' and 'Tainan, Taiwan, 736'.SummaryDifference0.2%

- Check41 days agoChange DetectedNo significant changes detected; the page content and structure appear the same as before, including study title, design, eligibility criteria, and locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check70 days agoChange Detected- Added a government-status notice and operating details, plus a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check77 days agoChange Detected- Version updated from v3.0.2 to v3.1.0. - No other content changes are specified.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.